Christian Martin Itin
CEO & DirectorDr. Christian Martin Itin, also known as Chris, Ph.D., has been the Chief Executive Officer of Autolus Therapeutics Plc. (Former Name: Autolus Limited) since March 3, 2016. Dr. Itin has been Director of Autolus Holdings (UK) Limited since June 15, 2018. He served as the Chief Executive Officer of Cytos Biotechnology AG (alternative name Cytos Biotechnology Ltd.) since October 2012 until January 2016 and its Member of Executive Board. He serves as a Director of Innate Pharma S.A since May 22, 2025. He served as the Chief Executive Officer and President of Micromet, Inc. from March 2004 to March 2, 2012. Before joining Micromet, he co-founded Zyomyx, Inc. Dr. Itin also served in the following capacities with Micromet, Inc.'s subsidiary Micromet AG, where he served in Various Executive positions which includes: served as the Chief Business Officer from April 2002 to March 2004, Vice President of Business and Corporate Development from September 2001 to April 2002, Vice President of Corporate Development from September 2000 to September 2001 and Head of IP and Licensing from September 1999 to September 2000. Dr. Itin joined Micromet in 1999. He held various positions at it focused on business and corporate development. During the last five years he has consolidated the relevant intellectual property space for it, established all corporate partnerships and significantly shaped the corporate strategy. He had been Chairman of Autolus Therapeutics Plc., (Former Name: Autolus Limited) since October 2014 until April 15, 2021. He serves as Director of Autolus Therapeutics Plc., since October 20, 2014. He served as Chairman of the Board of Kuros Biosciences AG since January 2016 until June 2018 and served as its Director since June 2018 until May 22, 2019. He served as the Chairman of Cytos Biotechnology AG since November 2012 until January 2016 and its Director since November 20, 2012. He has been a Non-Executive Director of Kymab Limited since September 2012. He has been a Director of Zyngenia, Inc. since October 11, 2012. Dr. Itin served as a Director of Micromet, Inc. from May 2006 to March 2, 2012. He studied Diploma in biology and PhD in Cell Biology from University of Basel, Switzerland and did post-doctoral research at the Biocenter of Basel University and Stanford University School of Medicine CA, USA.
公司職務
- 公司名稱Autolus Therapeutics plc股票代碼AUTL職務CEO & Director共事同僚
- MWMichael Weston BonneyIndependent Chairman of the Board
- MPMartin PuleFounder, Senior VP & Chief Scientific Officer
- RFRobert F. DolskiSenior VP & CFO
- CVChristopher VannSenior VP & COO
- PMPatrick McIlvennySenior VP of Finance, Chief Accounting Officer & Principal Accounting Officer
- LCLinda Cathavina BainIndependent Non-Executive Director
- CMCynthia Marie ButittaIndependent Non-Executive Director
- WDWilliam Douglas YoungIndependent Non-Executive Director
